Eur J Pediatr Surg 2013; 23(03): 254-256
DOI: 10.1055/s-0032-1322538
Case Gallery
Georg Thieme Verlag KG Stuttgart · New York

Management of Giant Omphalocele: A Case Series

Robert David Morgan
1   Department of Paediatric Surgery, Oxford University Hospitals, Oxford, United Kingdom
,
Lydia Hanna
1   Department of Paediatric Surgery, Oxford University Hospitals, Oxford, United Kingdom
,
Kokila Lakhoo
1   Department of Paediatric Surgery, Oxford University Hospitals, Oxford, United Kingdom
› Institutsangaben
Weitere Informationen

Publikationsverlauf

29. Februar 2012

12. Mai 2012

Publikationsdatum:
23. Oktober 2012 (online)

Preview

Introduction

Giant omphalocele (GO) is congenital abdominal wall defect measuring >6 cm and/or containing liver.[1] The omphalocele sac consists of amnion and peritoneum, and is prone to rupture either in utero, during delivery or after birth. The surgical management of neonates with GO is challenging. Several operative and nonoperative strategies have been described although a traditional silo chimney with graduated visceral reduction is commonly used. In this case report, we describe four patients with GO in whom postnatal management was highly problematic. We used an acellular biological xenograft called Surgisis Biodesign® (Cook Ltd.) to repair the GO.[2] Surgisis Biodesign is derived from porcine small intestine submucosa and consists of an extracellular matrix containing collagens, glycoproteins glycosaminoglycans, proteoglycans, and growth factors.[2] Once implanted into tissue it provides a scaffold for epithelialization.